Piramal Pharma Sees Significant Open Interest Surge Amid Active Market Engagement
Piramal Pharma Ltd has seen a notable rise in open interest, reaching 1,649 contracts, alongside a trading volume of 1,349 contracts. The stock's performance has improved compared to its sector, although it shows mixed trends relative to various moving averages. Delivery volume has decreased significantly, yet liquidity remains adequate.
Piramal Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 1,649 contracts, marking a rise of 239 contracts or 16.95% from the previous open interest of 1,410. This uptick in open interest coincides with a trading volume of 1,349 contracts, reflecting active market engagement.In terms of financial metrics, Piramal Pharma's performance today has outpaced its sector by 0.58%, indicating a positive shift after two consecutive days of decline. The stock's current price is positioned above its 5-day moving average but remains below the 20-day, 50-day, 100-day, and 200-day moving averages, suggesting mixed short- to medium-term trends.
Despite a notable drop in delivery volume, which has decreased by 58.29% compared to the 5-day average, the stock maintains sufficient liquidity for trades up to Rs 1.69 crore, based on 2% of the 5-day average traded value. The total futures and options value is reported at Rs 2,541.93 lakhs, with an underlying value of Rs 205.
In summary, the increase in open interest for Piramal Pharma highlights a notable shift in market dynamics, reflecting the stock's current performance and trading activity without delving into future implications.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
